Skip to main content
    G

    Genelux Corporation Common Stock (GNLX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.92
    +0.06 (+2.95%)

    Market Cap: $84.38M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Genelux Corporation Common Stock (GNLX) Earnings: Report Dates and Results

    Updated Nov 11, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    In the quarter ended Sep 30, 2026, Genelux Corporation Common Stock reported EPS of -$0.21, below the -$0.20 estimate. It beat the EPS estimate in 3 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    20%(3/15)
    Avg Surprise
    -25.47%

    Upcoming Estimates

    Report date not yet scheduledPeriod ending Dec 31, 2026
    EPS Consensus-$0.20
    Range-$0.23 - -$0.18
    7 analysts
    Revenue Consensus
    N/A
    RangeN/A
    7 analysts

    Next Report

    GNLX's report for the quarter ending Dec 31, 2026 is not on the earnings calendar yet.

    Earnings History

    Of the 15 quarters below that had an estimate, GNLX beat 3, missed 9 and matched 3. The widest gap in the table came in the quarter ended Mar 31, 2023, when EPS landed 231.25% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.21-$0.20-$0.22 - -$0.18-5.00%MissN/A62 up, 1 downNov 11, 2026N/A
    Jun 30, 2026-$0.21-$0.20-$0.22 - -$0.18-5.00%MissN/A62 up, 1 downAug 13, 2026N/A
    Mar 31, 2026-$0.20-$0.20-$0.26 - -$0.180.00%In lineN/A52 up, 0 downMay 7, 2026N/A
    Dec 31, 2025-$0.24-$0.22-$0.25 - -$0.20-9.94%MissN/A6N/AMar 19, 2026$8000
    Sep 30, 2025-$0.21-$0.23-$0.24 - -$0.20+8.70%BeatN/A53 up, 0 downNov 5, 2025N/A
    Jun 30, 2025-$0.20-$0.22-$0.24 - -$0.20+9.09%BeatN/A51 up, 0 downAug 7, 2025N/A
    Mar 31, 2025-$0.21-$0.24-$0.30 - -$0.19+12.50%BeatN/A40 up, 2 downMay 6, 2025N/A
    Dec 31, 2024-$0.25-$0.25N/A0.00%In lineN/A41 up, 0 downMar 28, 2025$896000
    Sep 30, 2024-$0.19-$0.19-$0.21 - -$0.170.00%In lineN/A41 up, 0 downNov 14, 2024N/A
    Jun 30, 2024-$0.22-$0.21-$0.26 - -$0.12-4.76%MissN/A30 up, 0 downAug 14, 2024N/A
    Mar 31, 2024-$0.29-$0.21-$0.26 - -$0.21-38.10%MissN/A20 up, 0 downMay 9, 2024$8000
    Dec 31, 2023-$0.25-$0.19-$0.22 - -$0.13-31.58%MissN/A40 up, 0 downMar 29, 2024$1.46M
    Sep 30, 2023-$0.20-$0.15-$0.22 - -$0.12-33.33%MissN/A30 up, 0 downNov 14, 2023N/A
    Jun 30, 2023-$0.23-$0.15-$0.19 - -$0.12-53.33%MissN/A20 up, 0 downAug 14, 2023N/A
    Mar 31, 2023-$0.53-$0.16-$0.16 - -$0.16-231.25%MissN/A10 up, 0 downMay 15, 2023$170000
    Dec 31, 2022-$0.12N/AN/AN/AN/AN/AN/AN/AJan 26, 2023$68000
    Jun 30, 2022-$0.12N/AN/AN/AN/AN/AN/AN/ASep 19, 2022N/A
    Mar 31, 2022-$0.16N/AN/AN/AN/AN/AN/AN/AJun 29, 2022N/A
    Last 18 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$0.86, after -$0.95 the year before. It was -$0.40 for the year ended Dec 31, 2022, the oldest of the 4 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$0.86N/A
    Dec 31, 2024-$0.95N/A
    Dec 31, 2023-$1.21N/A
    Dec 31, 2022-$0.40N/A

    Frequently Asked Questions About GNLX

    Did GNLX beat earnings estimates last quarter?

    No. Genelux Corporation Common Stock reported EPS of -$0.21 for the quarter ended Sep 30, 2026, below the -$0.20 estimate by 5.00%.

    What EPS do analysts expect from GNLX next quarter?

    The consensus EPS estimate for Genelux Corporation Common Stock for the quarter ending Dec 31, 2026 is -$0.20 from 7 analysts, with estimates from -$0.23 to -$0.18.

    How often does GNLX beat earnings estimates?

    Genelux Corporation Common Stock beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of +1.29%.